From the Open-Publishing Calendar
From the Open-Publishing Newswire
Indybay Feature
Important Marijuana Study Needs Chronic Pain Patients; Travel and Payment Included
Renowned medical researcher Donald Abrams, MD (and the Positive Health
Program of the UCSF Medical Service @ San Francisco General Hospital) is
seeking a few more patients for a government-funded study that features
patients who consume cannabis.
Program of the UCSF Medical Service @ San Francisco General Hospital) is
seeking a few more patients for a government-funded study that features
patients who consume cannabis.
Important Marijuana Study Needs Chronic Pain Patients; Travel and Payment Included
November 1, 2008
Dear NORML Supporters,
Renowned medical researcher Donald Abrams, MD (and the Positive Health
Program of the UCSF Medical Service @ San Francisco General Hospital) is
seeking a few more patients for a government-funded study that features
patients who consume cannabis.*
Patients accepted into the research program will have travel to San
Francisco covered and receive cash payments. This research program is part
of a continuum of medical cannabis-related research performed by Dr.
Abrams and his staff.
The goal’s study is to assess whether using vaporized marijuana affects
the safety of prescribed opiods in patients treated for chronic pain.
*To Join This Study You Must:
-Have Ongoing Chronic Pain
-Be 18 or older
-Be on a stable twice-daily dose of sustained-release oxycodone
(Oxycontin) for at least 2 weeks before enrollment
-Be willing to give up marijuana for a month prior to entering the study
-Not be a cigarette and/or cigar smoker, or be willing not to smoke for 2
weeks before starting the study
-Meet some additional criteria
If You Are Eligible You Will:
-Spend 5 days and nights in a clinical research center at San Francisco
General Hospital
-Have blood tests and other measurements done
-Inhale vaporized medicinal marijuana three times a day
If you’re interested in participating in this important medical research,
and qualify for the necessary research protocols, please directly contact
415-476-9554 (x315).
Absent these kinds of well constructed scientific research programs to
better understand and determine the medical utility of cannabinoids and
cannabis, the federal government will continuously oppose patient access
to whole-smoked cannabis, therefore this kind of research takes on an even
greater sense of concern and scope than just how a specific therapy
interacts with patients.
Cannabem liberemus,
-Allen St. Pierre
Executive Director
NORML / NORML Foundation
director [at] norml.org
November 1, 2008
Dear NORML Supporters,
Renowned medical researcher Donald Abrams, MD (and the Positive Health
Program of the UCSF Medical Service @ San Francisco General Hospital) is
seeking a few more patients for a government-funded study that features
patients who consume cannabis.*
Patients accepted into the research program will have travel to San
Francisco covered and receive cash payments. This research program is part
of a continuum of medical cannabis-related research performed by Dr.
Abrams and his staff.
The goal’s study is to assess whether using vaporized marijuana affects
the safety of prescribed opiods in patients treated for chronic pain.
*To Join This Study You Must:
-Have Ongoing Chronic Pain
-Be 18 or older
-Be on a stable twice-daily dose of sustained-release oxycodone
(Oxycontin) for at least 2 weeks before enrollment
-Be willing to give up marijuana for a month prior to entering the study
-Not be a cigarette and/or cigar smoker, or be willing not to smoke for 2
weeks before starting the study
-Meet some additional criteria
If You Are Eligible You Will:
-Spend 5 days and nights in a clinical research center at San Francisco
General Hospital
-Have blood tests and other measurements done
-Inhale vaporized medicinal marijuana three times a day
If you’re interested in participating in this important medical research,
and qualify for the necessary research protocols, please directly contact
415-476-9554 (x315).
Absent these kinds of well constructed scientific research programs to
better understand and determine the medical utility of cannabinoids and
cannabis, the federal government will continuously oppose patient access
to whole-smoked cannabis, therefore this kind of research takes on an even
greater sense of concern and scope than just how a specific therapy
interacts with patients.
Cannabem liberemus,
-Allen St. Pierre
Executive Director
NORML / NORML Foundation
director [at] norml.org
For more information:
http://www.norml.org
Add Your Comments
We are 100% volunteer and depend on your participation to sustain our efforts!
Get Involved
If you'd like to help with maintaining or developing the website, contact us.
Publish
Publish your stories and upcoming events on Indybay.
Topics
More
Search Indybay's Archives
Advanced Search
►
▼
IMC Network